Investigational Site Number : 1560001

Shenzhen 518053

0 studies enrolling now · 1 studies all time

What they study most

Plasma Cell Myeloma

Studies at this site

• A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) — Completed